A biological model of aphasia rehabilitation: Pharmacological perspectives

Aphasiology

Volumn 18, Issue 5-7, 2004, Pages 473-492

  Small, Steven L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMITRIPTYLINE; AMOBARBITAL; BIFEMELANE; BROMOCRIPTINE; CHLORDIAZEPOXIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; DIAZEPAM; DONEPEZIL; DOPAMINE RECEPTOR STIMULATING AGENT; DROPERIDOL; FLUOXETINE; HALOPERIDOL; LABETALOL; LORAZEPAM; MEPROBAMATE; METHYLPHENIDATE; NORTRIPTYLINE; PHENOXYBENZAMINE; PHENYTOIN; PIRACETAM; PLACEBO; PRAZOSIN; QUETIAPINE; SCOPOLAMINE; SEROTONIN UPTAKE INHIBITOR; UNINDEXED DRUG;

APHASIA; BEHAVIOR THERAPY; BIOLOGICAL MODEL; CEREBROVASCULAR ACCIDENT; DRUG ANTAGONISM; DRUG EFFICACY; DRUG MECHANISM; HUMAN; LANGUAGE DISABILITY; MEMORY DISORDER; NONHUMAN; REVIEW; SPEECH DISORDER; SPEECH REHABILITATION; SPEECH THERAPY;

EID: 2542503687     PISSN: 02687038     EISSN: None     Source Type: Journal    
DOI: 10.1080/02687030444000156     Document Type: Review

References (136)

1. Aarsland, D., Larsen, J. P., Reinvang, I., & Aasland, A. M. (1994). Effects of cholinergic blockade on language in healthy young women. Implications for the cholinergic hypothesis in dementia of the Alzheimer type. Brain, 117(6), 1377-1384.
2. Albert, M. L., Bachman, D. L., Morgan, A., & Helm-Estabrooks, N. (1988). Pharmacotherapy for aphasia. Neurology, 38(6), 877-879.
3. Andersen, G., Vestergaard, K., & Lauritzen, L. (1994). Effective treatment of poststroke depression with the selective serotonin reuptake inhibitor citalopram. Stroke, 25(6), 1099-1104.
4. Bakin, J. S., & Weinberger, N. M. (1996). Induction of a physiological memory in the cerebral cortex by stimulation of the nucleus basalis. Proceedings of the National Academy of Science, USA, 93(20), 11219-11224.
5. Baskerville, K. A., Schweitzer, J. B., & Herron, P. (1997). Effects of cholinergic depletion on experience-dependent plasticity in the cortex of the rat. Neuroscience, 80(4), 1159-1169.
6. Bergman, P. S., & Green, M. (1951). Aphasia: Effect of Intravenous Sodium Amytal. Neurology, 1, 471-475.
7. Berthier, M. L., Hinojosa, J., Martin Mdel, C., & Fernandez, I. (2003). Open-label study of donepezil in chronic poststroke aphasia. Neurology, 60(7), 1218-1219.
8. Boyeson, M. G. (1996). Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy [letter; comment]. Stroke, 27(11), 2145-2146.
9. Boyeson, M. G., & Feeney, D. M. (1984). The role of norepinephrine in recovery from brain injury (abstract). Annual Meeting of the Society for Neuroscience, 10, 68.
10. Boyeson, M. G., & Harmon, R. L. (1993). Effects of trazodone and desipramine on motor recovery in brain-injured rats. American Journal of Physical Medicine and Rehabilitation, 72(5), 286-293.
11. Boyeson, M. G., Harmon, R. L., & Jones, J. L. (1994). Comparative effects of fluoxetine, amitriptyline and serotonin on functional motor recovery after sensorimotor cortex injury. American Journal of Physical Medicine and Rehabilitation, 73(2), 76-83.
12. Bracco, L., Tiezzi, A., Ginanneschi, A., Campanella, C., & Amaducci, L. (1984). Lateralization of choline acetyltransferase (ChAT) activity in fetus and adult human brain. Neuroscience Letters, 50(1-3), 301-305.
13. Bragoni, M., Altieri, M., Di Piero, V., Padovani, A., Mostardini, C., & Lenzi, G. L. (2000). Bromocriptine and speech therapy in non-fluent chronic aphasia after stroke. Neurological Sciences, 21(1), 19-22.
14. Brown, R. M., Carlson, A., Ljungren, B. L., Seisjö, B. K., & Snider, S. R. (1974). Effect of ischemia on monoamine metabolism in the brain. Acta Scandinavica Physiologica, 90, 789-791.
15. Castren, E., Zafra, F., Thoenen, H., & Lindholm, D. (1992). Light regulates expression of brain-derived neurotrophic factor mRNA in rat visual cortex. Proceedings of the National Academy of Science, USA, 89(20), 9444-9448.
16. CEBM (Centre for Evidence-Based Medicine). (2003). Vol. 2003. University Department of Psychiatry, Warneford Hospital, Headington, Oxford, UK.
17. Clark, A. N. G., & Mankikar, G. D. (1979). d-Amphetamine in elderly patients refractory to rehabilitation procedures. Journal of the American Geriatrics Society, 27(4), 174-177.
18. Cohen, H. P., Woltz, A. G., & Jacobson, R. L. (1975). Catecholamine content of cerebral tissue after occlusion or manipulation of middle cerebral artery in cats. Journal of Neurosurgery, 43, 32-36.
19. Connors, J. J. III (2002). Interventional stroke therapy: The potential benefit of direct intra-arterial infusion. Reviews in Cardiovascular Medicine, 3 Suppl 2, S92-99.
20. Crisostomo, E. A., Duncan, P. W., Propst, M., Dawson, D. V., & Davis, J. N. (1988). Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Annals of Neurology, 23, 94-97.
21. Darley, F. L., Keith, R. L., & Sasanuma, S. (1977). The effect of alerting and tranquilizing drugs upon the performance of aphasic patients. Clinical Aphasiology, 7, 91-96.
22. De Deyn, P. P., Reuck, J. D., Deberdt, W., Vlietinck, R., & Orgogozo, J. M. (1997). Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group. Stroke, 28(12), 2347-2352.
23. De Keyser, J., Sulter, G., & Luiten, P. G. (1999). Clinical trials with neuroprotective drugs in acute ischaemic stroke: Are we doing the right thing? Trends in Neuroscience, 22(12), 535-540.
24. Dixon, C. E., Hamm, R. J., Taft, W. C., & Hayes, R. L. (1994). Increased anticholinergic sensitivity following closed skull impact and controlled cortical impact traumatic brain injury in the rat. Journal of Neurotrauma, 11(3), 275-287.
25. Downhill, J. R. Jr., & Robinson, R. G. (1994). Longitudinal assessment of depression and cognitive impairment following stroke. Journal of Nervous and Mental Disease, 182(8), 425-431.
26. Enderby, P., Broeckx, J., Hospers, W., Schildermans, F., & Deberdt, W. (1994). Effect of piracetam on recovery and rehabilitation after stroke: A double-blind, placebo-controlled study. Clinical Neuropharmacology, 17(4), 320-331.
27. Feeney, D. M., Gonzalez, A., & Law, W. A. (1982). Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science, 217, 855-857.
28. Feeney, D. M., & Hovda, D. A. (1983). Amphetamine and apomorphine restore tactile placing after motor cortex injury in the cat. Psychopharmacology, 79, 67-71.
29. Feeney, D. M., & Hovda, D. A. (1985). Reinstatement of binocular depth perception by amphetamine and visual experience after visual cortex ablation. Brain Research, 342, 352-356.
30. Féré, C. (1886). La rééducation des aphasiques. Revue Générale de Clinique et de Thé rapeutique, 785.
31. Freund, H. J., Sabel, B. A., & Witte, O. W. (Ed.). (1997). Brain plasticity. Philadelphia, PA: Lippencott-Raven Publishers.
32. Friel, K. M., & Nudo, R. J. (1998). Recovery of motor function after focal cortical injury in primates: Compensatory movement patterns used during rehabilitative training. Somatosensory and Motor Research, 15(3), 173-189.
33. Fruehwald, S., Gatterbauer, E., Rehak, P., & Baumhackl, U. (2003). Early fluoxetine treatment of post-stroke depression - a three-month double-blind placebo-controlled study with an open-label long-term follow up. Journal of Neurology, 250(3), 347-351.
34. Gernsbacher, M. A., & St. John, M. F. (1998). Learning and losing syntax: Practice makes perfect and frequency builds fortitude. In J. L. E. Bourne (Ed.), Foreign language learning: Psycholinguistic experiments on training and retention (pp. 231-255). Mawah, NJ: Laurence Erlbaum Associates Inc.
35. Gil, R., & Neau, J. P. (1995). Rapid aggravation of aphasia by vigabatrin. Journal of Neurology, 242(4), 251-252.
36. Giurgea, C. E., Greindl, M. G., & Preat, S. (1983). Nootropic drugs and aging. Acta Psychiatrica Belgica, 83(4), 349-358.
37. Goldberg, E., Gerstman, L. J., Mattis, S., Hughes, J. E., Sirio, C. A., & Bilder, R. M. Jr. (1982). Selective effects of cholinergic treatment on verbal memory in posttraumatic amnesia. Journal of Clinical Neuropsychology, 4(3), 219-234.
38. Goldstein, L. B. (1993). Basic and clinical studies of pharmacologic effects on recovery from brain injury. Journal of Neural Transplantation & Plasticity, 4(3), 175-192.
39. Goldstein, L. B. (1995). Common drugs may influence motor recovery after stroke: The sygen in acute stroke study investigators [see comments]. Neurology, 45(5), 865-871.
40. Goldstein, L. B. (1998a). Potential effects of common drugs on stroke recovery. Archives of Neurology, 55(4), 454-467
41. Goldstein, L. B. (Ed.). (1998b). Restorative neurology: Advances in pharmacotherapy for recovery after stroke. Armonk, NY: Futura Publishing Company.
42. Goldstein, L. B. (1999). Pharmacological approach to functional reorganization: The role of norepinephrine. Revue Neurologique (Paris), 155(9), 731-736.
43. Goldstein, L. B. (2000a). Effects of amphetamines and small related molecules on recovery after stroke in animals and man. Neuropharmacology, 39(5), 852-859.
44. Goldstein, L. B. (2000b). Should antihypertensive therapies be given to patients with acute ischemic stroke? Drug Safety, 22(1), 13-18.
45. Goldstein, L. B. (2003). Amphetamines and related drugs in motor recovery after stroke. Physical Medicine and Rehabilitation Clinics of North America, 14(1 Suppl), S125-134, x.
46. Goldstein, L. B., & Bullman, S. (1997). Effects of dorsal noradrenergic bundle lesions on recovery after sensorimotor cortex injury. Pharmacology, Biochemistry and Behavior, 58(4), 1151-1157.
47. Goldstein, L. B., Miller, G. D., Cress, N. M., Tyson, A. G., & Davis, J. N. (1988). Studies of an animal model for the recovery of function after stroke (abstract). Annals of Neurology, 22, 159-160.
48. Grade, C., Redford, B., Chrostowski, J., Toussaint, L., & Blackwell, B. (1998). Methylphenidate in early poststroke recovery: A double-blind, placebo-controlled study. Archives of Physical Medicine and Rehabilitation, 79(9), 1047-1050.
49. Greener, J., Enderby, P., & Whurr, R. (2001). Pharmacological treatment for aphasia following stroke. Cochrane Database Syst Rev(4), CD000424.
50. Grotta, J. C. (1987). Current medical and surgical therapy for cerebrovascular disease. New England Journal of Medicine, 317(24), 1505-1516.
51. Gupta, S. R., & Mlcoch, A. G. (1992). Bromocriptine treatment of nonfluent aphasia. Archives of Physical Medicine and Rehabilitation, 73, 373-376.
52. Gupta, S. R., Mlcoch, A. G., Scolaro, C., & Moritz, T. (1995). Bromocriptine treatment of nonfluent aphasia. Neurology, 45(12), 2170-2173.
53. Gustafson, Y., Nilsson, I., Mattsson, M., Astrom, M., & Bucht, G. (1995). Epidemiology and treatment of poststroke depression. Drugs and Aging, 7(4), 298-309.
54. Hacke, W., Kaste, M., Fieschi, C., Toni, D., Lesaffre, E., von Kummer, R. et al. (1995). Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). Journal of the American Medical Association, 274(13), 1017-1025.
55. Hamm, R. J., O'Dell, D. M., Pike, B. R., & Lyeth, B. G. (1993). Cognitive impairment following traumatic brain injury: The effect of pre- and post-injury administration of scopolamine and MK-801. Brain Research: Cognitive Brain Research, 1(4), 223-226.
56. Helmuth, L. (2003). Aging. The wisdom of the wizened. Science, 299(5611), 1300-1302.
57. Hendry, S. H., Schwark, H. D., Jones, E. G., & Yan, J. (1987). Numbers and proportions of GABA-immunoreactive neurons in different areas of monkey cerebral cortex. Journal of Neuroscience, 7(5), 1503-1519.
58. Hernandez, T. D., & Holling, L. C. (1994). Disruption of behavioral recovery by the anti-convulsant phenobarbital. Brain Research, 635(1-2), 300-306.
59. Hovda, D. A., & Feeney, D. M. (1984). Amphetamine with experience promotes recovery of locomotor function after unilateral frontal cortex injury in the cat. Brain Research, 298, 358-361.
60. Huber, W. (1999). The role of piracetam in the treatment of acute and chronic aphasia. Pharmacopsychiatry, 32(Suppl 1), 38-43.
61. Huber, W., Willmes, K., Poeck, K., Van Vleymen, B., & Deberdt, W. (1997). Piracetam as an adjuvant to language therapy for aphasia: A randomized double-blind placebo-controlled pilot study. Archives of Physical Medicine and Rehabilitation, 78(3), 245-250.
62. Hughes, J. D., Jacobs, D. H., & Heilman, K. M. (2000). Neuropharmacology and linguistic neuroplasticity. Brain and Language, 71(1), 96-101.
63. Jacobs, D., Shuren, J., Gold, M., Adair, J., Bowers, D., Williamson, D. et al. (1996). Physostigmine pharmacotherapy for anomia. Neurocase, 2(2), 83-91.
64. Jacobs, K. M., & Donoghue, J. P. (1991). Reshaping the cortical motor map by unmasking latent intracortical connections. Science, 251(4996), 944-947.
65. Jambaque, I., Chiron, C., Kaminska, A., Plouin, P., & Dulac, O. (1998). Transient motor aphasia and recurrent partial seizures in a child: Language recovery upon seizure control. Journal of Child Neurology, 13(6), 296-300.
66. Jenkins, W. M., & Merzenich, M. M. (1987). Reorganization of neocortical representations after brain injury: A neurophysiological model of the bases of recovery from stroke. Progress in Brain Research, 71, 241-266.
67. Johansson, B. B. (2000). Brain plasticity and stroke rehabilitation. The Willis lecture. Stroke, 31(1), 223-230.
68. Kent, T. A., Quast, M., Taglialatela, G., Rea, C., Wei, J., Tao, Z. et al. (1999). Effect of NGF treatment on outcome measures in a rat model of middle cerebral artery occlusion. Journal of Neuroscience Research, 55(3), 357-369.
69. Kessler, J., Thiel, A., Karbe, H., & Heiss, W. D. (2000). Piracetam improves activated blood flow and facilitates rehabilitation of poststroke aphasic patients. Stroke, 31(9), 2112-2116.
70. Kilgard, M. P., & Merzenich, M. M. (1998). Cortical map reorganization enabled by nucleus basalis activity. Science, 279(5357), 1714-1718.
71. Koller, G., Satzger, W., Adam, M., Wagner, M., Kathmann, N., Soyka, M. et al. (2003). Effects of scopolamine on matching to sample paradigm and related tests in human subjects. Neuropsychobiology, 48(2), 87-94.
72. Kondziolka, D., Wechsler, L., & Achim, C. (2002). Neural transplantation for stroke. Journal of Clinical Neuroscience, 9(3), 225-230.
73. Kondziolka, D., Wechsler, L., Gebel, J., DeCesare, S., Elder, E., & Meltzer, C. C. (2003). Neuronal transplantation for motor stroke: from the laboratory to the clinic. Physical Medicine and Rehabilitation Clinics of North America, 14(1 Suppl), S153-160, xi.
74. Kondziolka, D., Wechsler, L., Goldstein, S., Meltzer, C., Thulborn, K. R., Gebel, J. et al. (2000). Transplantation of cultured human neuronal cells for patients with stroke. Neurology, 55(4), 565-569.
75. Lazarus, L. W., Winemiller, D. R., Lingam, V. R., Neyman, I., Hartman, C., Abassian, M. et al. (1992). Efficacy and side effects of methylphenidate for poststroke depression [see comments]. Journal of Clinical Psychiatry, 53(12), 447-449.
76. Lecours, A. R., Lhermitte, F., & Bryans, B. (1983). Aphasiology. London: Baillière Tindall.
77. Linn, L. (1947). Sodium amytal in treatment of aphasia. Archives of Neurology and Psychiatry, 58, 357-358.
78. Lipsey, J. R., Robinson, R. G., Pearlson, G. D., Rao, K., & Price, T. R. (1984). Nortriptyline treatment of poststroke depression: A double-blind study. Lancet, 1(8372), 297-300.
79. Lutsep, H., & Clark, W. (2001). An update of neuroprotectants in clinical development for acute stroke. Current Opinion in Investigational Drugs, 2(12), 1732-1736.
80. Lyeth, B. G., Ray, M., Hamm, R. J., Schnabel, J., Saady, J. J., Poklis, A. et al. (1992). Postinjury scopolamine administration in experimental traumatic brain injury. Brain Research, 569(2), 281-286.
81. Macklis, J. D. (1993). Transplanted neocortical neurons migrate selectively into regions of neuronal degeneration produced by chromophore-targeted laser photolysis. Journal of Neuroscience, 13(9), 3848-3863.
82. MacLennan, D. L., Nicholas, L. E., Morley, G. K., & Brookshire, R. H. (1991). The effects of bromocriptine on speech and language function in a man with transcortical motor aphasia. Clinical Aphasiology, 21, 145-155.
83. McCloskey, M., & Cohen, N. J. (1989). Catastrophic interference in connectionist networks: The sequential learning problem. In G. Bower (Ed.), The psychology of learning and motivation (pp. 109-165). New York: Academic Press.
84. Merzenich, M. M., Nelson, R. J., Stryker, M. P., Cynader, M. S., Schoppmann, A., & Zook, J. M. (1984). Somatosensory cortical map changes following digit amputation in adult monkeys. Journal of Comparative Anatomy, 224, 591-605.
85. Montanez, S., Kline, A. E., Gasser, T. A., & Hernandez, T. D. (2000). Phenobarbital administration directed against kindled seizures delays functional recovery following brain insult [In Process Citation]. Brain Research, 860(1-2), 29-40.
86. Morris, P. L., Raphael, B., & Robinson, R. G. (1992). Clinical depression is associated with impaired recovery from stroke. Medical Journal of Australia, 157(4), 239-242.
87. Mula, M., Trimble, M. R., Thompson, P., & Sander, J. W. (2003). Topiramate and word-finding difficulties in patients with epilepsy. Neurology, 60(7), 1104-1107.
88. Mulrow, C., & Cook, D. (1998). Systematic reviews: Synthesis of best evidence for health care decisions. Philadelphia, PA: American College of Physicians.
89. Neville, H. J., & Bavelier, D. (1998). Neural organization and plasticity of language. Current Opinion in Neurobiology, 8(2), 254-258.
90. Nudo, R. J., & Friel, K. M. (1999). Cortical plasticity after stroke: Implications for rehabilitation. Revue Neurologique (Paris), 155(9), 713-717.
91. Nudo, R. J., Wise, B. M., SiFuentes, F., & Milliken, G. W. (1996). Neural substrates for the effects of rehabilitative training on motor recovery after ischemic infarct. Science, 272(5269), 1791-1794.
92. Olson, L., Backman, L., Ebendal, T., Eriksdotter-Jonhagen, M., Hoffer, B., Humpel, C. et al. (1994). Role of growth factors in degeneration and regeneration in the central nervous system; clinical experiences with NGF in Parkinson's and Alzheimer's diseases. Journal of Neurology, 242(1 Suppl 1), S12-15.
93. Orgogozo, J. M. (1999). Piracetam in the treatment of acute stroke. Pharmacopsychiatry, 32 (Suppl 1), 25-32.
94. Pashek, G. V., & Bachman, D. L. (2003). Cognitive, linguistic and motor speech effects of donepezil hydrochloride in a patient with stroke-related aphasia and apraxia of speech. Brain and Language, 87(1), 179-180.
95. Petersen, R. C. (1977). Scopolamine induced learning failures in man. Psychopharmacology (Berlin), 52(3), 283-289.
96. Porch, B., Wyckes, J., & Feeney, D. M. (1985). Haloperidol, thiazides, and some antihypertensives slow recovery from aphasia (abstract). Annual Meeting of the Society for Neuroscience, 11, 52.
97. Porch, B. E. (1967). Porch Index of Communicative Ability: Volume 1: Theory and development. Palo Alto, CA: Consulting Psychologists Press.
98. Robinson, R. G. (1998). The clinical neuropsychiatry of stroke: Cognitive, behavioral and emotional disorders following vascular brain injury. Cambridge: Cambridge University Press.
99. Robinson, R. G., Kubos, K. L., Starr, L. B., Rao, K., & Price, T. R. (1984). Mood disorders in stroke patients: Importance of location of lesion. Brain, 107, 81-93.
100. Robinson, R. G., Schultz, S. K., Castillo, C., Kopel, T., Kosier, J. T., Newman, R. M. et al. (2000). Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: A placebo-controlled, double-blind study. American Journal of Psychiatry 157(3), 351-359.
101. Robinson, R. G., Shoemaker, W. J., & Schlumpf, M. (1980). Time course of changes in catecholamines following right hemisphere cerebral infarction in the rat. Brain Research, 181, 202-208.
102. Robinson, R. G., Shoemaker, W. J., Schlumpf, M., Valk, T., & Bloom, F. E. (1975). Effect of experimental cerebral infarction in rat brain on catecholamines and behavior. Nature, 255, 332-334.
103. Rocamora, N., Welker, E., Pascual, M., & Soriano, E. (1996). Upregulation of BDNF mRNA expression in the barrel cortex of adult mice after sensory stimulation. Journal of Neuroscience, 16(14), 4411-4419.
104. Sabe, L., Leiguarda, R., & Starkstein, S. E. (1992). An open-label trial of bromocriptine in nonfluent aphasia. Neurology, 42, 1637-1638.
105. Sackett, D., Richardson, W., Rosenberg, W., & Haynes, R. (2000). Evidence-based medicine: How to practice and teach EBM (2nd ed.). New York: Churchill Livingstone.
106. Saija, A., Robinson, S. E., Lyeth, B. G., Dixon, C. E., Yamamoto, T., Clifton, G. L. et al. (1988). The effects of scopolamine and traumatic brain injury on central cholinergic neurons. Journal of Neurotrauma, 5(2), 161-170.
107. Sarno, M. T., Sarno, J. E., & Diller, L. (1972). The effect of hyperbaric oxygen on communication function in adults with aphasia secondary to stroke. Journal of Speech and Hearing Research, 15, 42-48.
108. Schallert, T., Jones, T., Weaver, M., Shapiro, L., Crippens, D., & Fulton, R. (1992). Pharmacologic and anatomic considerations in recovery of function. Phys Med Rehabil, 6, 375-393.
109. Sherman, S. J., Atri, A., Hasselmo, M. E., Stern, C. E., & Howard, M. W. (2003). Scopolamine impairs human recognition memory: Data and modeling. Behavioural Neuroscience, 117(3), 526-539.
110. Singh, A., Herrmann, N., & Black, S. E. (1998). The importance of lesion location in poststroke depression: A critical review. Canadian Journal of Psychiatry, 43(9), 921-927.
111. Small, S. L. (1994). Pharmacotherapy of Aphasia: A Critical Review. Stroke, 25(6), 1282-1289.
112. Small, S. L. (2000). The future of aphasia treatment. Brain and Language, 71(1), 227-232.
113. Small, S. L. (2001). Biological approaches to the treatment of aphasia. In A. Hillis (Ed.), Handbook on adult language disorders: Integrating cognitive neuropsychology, neurology, and rehabilitation (pp. 397-411). Philadelphia, PA: Psychology Press.
114. Small, S. L., & Burton, M. W. (2001). Functional neuroimaging of language. In R. S. Berndt (Ed.), Handbook of neuropsychology. Vol. 3: Language and aphasia (2nd ed., pp. 335-351). Amsterdam: Elsevier.
115. Snyder, E. Y., Yoon, C., Flax, J. D., & Macklis, J. D. (1997). Multipotent neural precursors can differentiate toward replacement of neurons undergoing targeted apoptotic degeneration in adult mouse neocortex. Proceedings of the National Academy of Science, USA, 94(21), 11663-11668.
116. Starkstein, S. E., Bryer, J. B., Berthier, M. L., Cohen, B., Price, T. R., & Robinson, R. G. (1991). Depression after stroke: The importance of cerebral hemisphere asymmetries. Journal of Neuropsychiatry and Clinical Neuroscience, 3(3), 276-285.
117. Starkstein, S. E., & Robinson, R. G. (1989). Affective disorders and cerebral vascular disease. British Journal of Psychiatry, 154, 170-182.
118. Stroemer, R. P., Kent, T. A., & Hulsebosch, C. E. (1995). Neocortical neural sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats. Stroke, 26(11), 2135-2144.
119. Stroemer, R. P., Kent, T. A., & Hulsebosch, C. E. (1998). Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats. Stroke, 29(11), 2381-2393.
120. Taffe, M. A., Weed, M. R., & Gold, L. H. (1999). Scopolamine alters rhesus monkey performance on a novel neuropsychological test battery. Brain Research: Cognitive Brain Research, 8(3), 203-212.
121. Tanaka, Y., Miyazaki, M., & Albert, M. L. (1997). Effects of increased cholinergic activity on naming in aphasia. Lancet, 350(9071), 116-117.
122. Task Force on DSM-IV (1994). Diagnostic and Statistical Manual of Mental Disorders - IV (Text Revision) (4th ed.). Washington DC: American Psychiatric Association.
123. The NINDS rt-PA Stroke Study Group (1995). Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine, 333(24), 1581-1587.
124. Tsz-Ming, C., & Kaufer, D. (2001). Effects of donepezil on aphasia, agnosia, and apraxia in patients with cerebrovascular lesions [abstract]. Journal of Neuropsychiatry and Clinical Neurosciences, 13, 140.
125. van de Weg, F. B., Kuik, D. J., & Lankhorst, G. J. (1999). Post-stroke depression and functional outcome: A cohort study investigating the influence of depression on functional recovery from stroke. Clinical Rehabilitation, 13(3), 268-272.
126. Vernon, M. W., & Sorkin, E. M. (1991). Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders. Drugs and Aging, 1(1), 17-35.
127. Walker-Batson, D. (2000). Use of pharmacotherapy in the treatment of aphasia. Brain and Language, 71(1), 252-254.
128. Walker-Batson, D., Devous, M. D., Curtis, S., Unwin, D. H., & Greenlee, R. G. (1991). Response to amphetamine to facilitate recovery from aphasia subsequent to stroke. Clinical Aphasiology, 21, 137-143.
129. Walker-Batson, D., Smith, P., Curtis, S., Unwin, H., & Greenlee, R. (1995). Amphetamine paired with physical therapy accelerates motor recovery after stroke. Further evidence. Stroke, 26(12), 2254-2259.
130. West, R., & Stockel, S. (1965). The effect of meprobamate on recovery from aphasia. Journal of Speech and Hearing Research, 8, 57-62.
131. Whitehouse, P. J., Price, D. L., Clark, A. W., Coyle, J. T., & DeLong, M. R. (1981). Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis. Annals of Neurology, 10(2), 122-126.
132. Wong, I. C., & Lhatoo, S. D. (2000). Adverse reactions to new anticonvulsant drugs. Drug Safety, 23(1), 35-56.
133. Xerri, C., Merzenich, M. M., Peterson, B. E., & Jenkins, W. (1998). Plasticity of primary somatosensory cortex paralleling sensorimotor skill recovery from stroke in adult monkeys. Journal of Neurophysiology, 79(4), 2119-2148.
134. Yu, A. J., & Dayan, P. (2002). Acetylcholine in cortical inference. Neural Networks, 15(4-6), 719-730.
135. Zhang, W. R., Kitagawa, H., Hayashi, T., Sasaki, C., Sakai, K., Warita, H. et al. (1999). Topical application of neurotrophin-3 attenuates ischemic brain injury after transient middle cerebral artery occlusion in rats. Brain Research, 842(1), 211-214.
136. Zlokovic, B. V., & Apuzzo, M. L. (1997). Cellular and molecular neurosurgery: Pathways from concept to reality - part II: Vector systems and delivery methodologies for gene therapy of the central nervous system. Neurosurgery, 40(4), 805-812; discussion 812-813.